Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayat G Lashen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer|April 28, 2023
Reply to "Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10%"Ayat G Lashen, Michael S Toss, Emad A Rakha
Cancer|January 19, 2023
The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-upAyat G Lashen, Michael S Toss, Nigel P Mongan, et al.
Histopathology|August 29, 2021
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational studyAyat G Lashen, Michael S Toss, Ayaka Katayama, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 13, 2021
Defining the area of mitoses counting in invasive breast cancer using whole slide imageAsmaa Ibrahim, Ayat G Lashen, Ayaka Katayama, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|August 27, 2024
Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast CancerAyat G Lashen, Michael S Toss, Catrin S Rutland, et al.
Histopathology|May 24, 2023
Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancerAyat G Lashen, Michael S Toss, Louisa Wootton, et al.
International Journal of Molecular Sciences|November 9, 2024
Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast CancerBusra Erkan, Skye MacIntyre, Charlotte Brown, et al.
Histopathology|June 13, 2024
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation studyAyat G Lashen, Michael Toss, Islam Miligy, et al.
Pathology|July 6, 2024
The characteristics and prognostic significance of histone H1 expression in breast cancerAyat G Lashen, Nabeelah Almalki, Michael Toss, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 28, 2023
Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical ApplicationAsmaa Ibrahim, Mostafa Jahanifar, Noorul Wahab, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer|April 28, 2023
Reply to "Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10%"Ayat G Lashen, Michael S Toss, Emad A Rakha
Cancer|January 19, 2023
The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-upAyat G Lashen, Michael S Toss, Nigel P Mongan, et al.
Histopathology|August 29, 2021
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational studyAyat G Lashen, Michael S Toss, Ayaka Katayama, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 13, 2021
Defining the area of mitoses counting in invasive breast cancer using whole slide imageAsmaa Ibrahim, Ayat G Lashen, Ayaka Katayama, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|August 27, 2024
Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast CancerAyat G Lashen, Michael S Toss, Catrin S Rutland, et al.
Histopathology|May 24, 2023
Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancerAyat G Lashen, Michael S Toss, Louisa Wootton, et al.
International Journal of Molecular Sciences|November 9, 2024
Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast CancerBusra Erkan, Skye MacIntyre, Charlotte Brown, et al.
Histopathology|June 13, 2024
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation studyAyat G Lashen, Michael Toss, Islam Miligy, et al.
Pathology|July 6, 2024
The characteristics and prognostic significance of histone H1 expression in breast cancerAyat G Lashen, Nabeelah Almalki, Michael Toss, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 28, 2023
Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical ApplicationAsmaa Ibrahim, Mostafa Jahanifar, Noorul Wahab, et al.
Pageof 2